NCT05661123

Brief Summary

this study will be designed to investigate the therapeutic benefits of kinesio tape in combination to complete decongestive therapy on limb volume , skin fibrosis, functional capacity ,ankle range of motion, lymphedema associated symptoms (pain, tightness, heaviness and hardness) and quality of life in patients with lower limbs fibrosis post cellulitis ,as well as finding out a physical therapy approach that has positive effect in treatment and care such cases which would enhance the physical therapy field.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 27, 2022

Completed
25 days until next milestone

First Posted

Study publicly available on registry

December 22, 2022

Completed
9 months until next milestone

Study Start

First participant enrolled

September 20, 2023

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2024

Completed
Last Updated

August 30, 2023

Status Verified

August 1, 2023

Enrollment Period

5 months

First QC Date

November 27, 2022

Last Update Submit

August 28, 2023

Conditions

Keywords

Lymphedemacomplete decongestive therapykinesio tape

Outcome Measures

Primary Outcomes (4)

  • To assess limb volume

    using Circumferential tape measurement to measure round measurements in cm at the beginning of the study then every 3 sessions

    6 weeks

  • To assess skin extensibility

    using tonometer at the beginning of the study and at last session after 6 weeks

    6 weeks

  • To evaluate ankle range of motion

    using digital goniometer at the ankle joint to assess the dorsi flexion degree at the beginning of the study and at the last session

    6 weeks

  • To evaluate patient quality of life

    using Lymphedema life impact scale in form of 18 questions every question' answer from 0 ( no symptoms) to 4 ( sever symptoms) at the beginning of the study and at the end of sessions

    6 weeks

Study Arms (2)

will receive kinesio tape in addition to complete decongestive therapy for 6 successive weeks.

EXPERIMENTAL

will receive Complete decongestive therapy in combination with kinesio tape

Other: Complete decongestive therapy

will receive complete decongestive therapy for 6 successive weeks.

OTHER

Complete Decongestive Therapy(traditional physical therapy) that includes: 1. Education. 2. Skin care . 3. Pneumatic compression device . 4. Manual lymph draining . 5. Multilayer short stretch compression bandages. 6. Exercises.

Other: Complete decongestive therapy

Interventions

1. Education. 2. Skin care . 3. Pneumatic compression device . 4. Manual lymph draining . 5. Multilayer short stretch compression bandages. 6. Exercises.

will receive complete decongestive therapy for 6 successive weeks.will receive kinesio tape in addition to complete decongestive therapy for 6 successive weeks.

Eligibility Criteria

Age45 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • The patient will be according the following criteria:-
  • Males and females with Lower limb lymphedema Stage 2.
  • Age will range from45 to 55years old.
  • BMI \<40 (kg/m2).
  • All patients will be clinically and medically stable when attending the study.
  • Patients free from any acute conditions.
  • Post cellulitis for at least 2 weeks.

You may not qualify if:

  • Unstable cardiovascular problems.
  • Altered mental status or poor cognition.
  • Lower limb ischemia (ABI ≤0.8).
  • Lower limb lymphedema stage 3\&4.
  • Acute deep venous thrombosis.
  • Any acute infection.
  • Patients with orthopedic or neurological limitations to exercise.
  • Any lower limb acute ulcer or arterial wounds.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Al Sahel teaching hospital

Cairo, Egypt

RECRUITING

MeSH Terms

Conditions

FibrosisLymphedema

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and SymptomsLymphatic DiseasesHemic and Lymphatic Diseases

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physical therapist and Certified lymphedema therapist

Study Record Dates

First Submitted

November 27, 2022

First Posted

December 22, 2022

Study Start

September 20, 2023

Primary Completion

March 1, 2024

Study Completion

June 1, 2024

Last Updated

August 30, 2023

Record last verified: 2023-08

Locations